Related Experiment Videos
[Lymphocyte apoptosis in non-ST segment elevation acute myocardial infarction ]
Anna Laura Pasqui1, Michela Di Renzo, Giovanni Bova
1Sezione di Semeiotica Medica, Dipartimento di Medicina Clinica e Scienze Immunologiche, Università degli Studi di Siena. pasquian@unisi.it
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|November 19, 2003
Summary
Peripheral lymphocytes in non-ST elevation myocardial infarction (NSTEMI) patients show increased apoptosis and activation. This programmed cell death, linked to plaque rupture, may precede acute ischemia, impacting myocardial injury.
Area of Science:
- Immunology
- Cardiology
- Cell Biology
Background:
- Lymphocytes are implicated in coronary plaque destabilization during acute coronary syndromes.
- Understanding lymphocyte behavior in myocardial infarction is crucial for therapeutic development.
Purpose of the Study:
- To evaluate circulating lymphocyte apoptosis in non-ST elevation myocardial infarction (NSTEMI) patients.
- To compare NSTEMI patients with stable angina and healthy controls regarding lymphocyte apoptosis and activation markers.
Main Methods:
- Assessed spontaneous lymphomonocyte apoptosis and IL-2 production via ELISA.
- Measured Fas expression on T cells and Fas ligand mRNA using flow cytometry and RT-PCR.
- Investigated T-cell activation markers (HLA-DR, CD69) and subpopulations (CD4/CD8 ratio).
Main Results:
- NSTEMI patients exhibited significantly increased spontaneous lymphocyte apoptosis compared to controls.
- Enhanced apoptosis correlated with increased Fas expression and susceptibility to Fas agonist.
- Elevated HLA-DR+ CD3+ and CD69+ CD4+ T cells indicated T-cell activation in NSTEMI patients.
Conclusions:
- Enhanced lymphocyte apoptosis in NSTEMI is an active, antigen-driven process mediated by death cytokines.
- Peripheral lymphocytes in NSTEMI are activated, undergoing enhanced programmed cell death.
- Lymphocyte activation likely precedes ischemia and contributes to plaque rupture and myocardial damage.